Efficacy of Imatinib in Patients with Platelet-Derived Growth Factor Receptor Alpha–Mutated Gastrointestinal Stromal Tumors

PURPOSE: The incidence of gastrointestinal stromal tumors (GISTs) harboring platelet-derived growth factor receptor alpha (PDGFRA) mutations is low, therefore further investigation of the efficacy of imatinib in this subgroup was needed. MATERIALS AND METHODS: Patients with PDGFRA-mutant GISTs who r...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Res Treat
Hlavní autoři: Yoo, Changhoon, Ryu, Min-Hee, Jo, Jungmin, Park, Inkeun, Ryoo, Baek-Yeol, Kang, Yoon-Koo
Médium: Artigo
Jazyk:Inglês
Vydáno: Korean Cancer Association 2016
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4843750/
https://ncbi.nlm.nih.gov/pubmed/26130666
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2015.015
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky